Study Design and Baseline Characteristics of Patients with T2DM in the Post-marketing Safety Study of Dulaglutide in China (TRUST-CHN)

BACKGROUND: TRUST-CHN is a prospective, post-marketing safety study in patients with type 2 diabetes mellitus (T2DM) in China to evaluate the safety and effectiveness of dulaglutide in real-world clinical practice. We report here the study design and baseline characteristics of enrolled patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lixin, Li, Li, Yu, Qiurong, Wang, Na, Chen, Jun, Wang, Zhiquan, Ding, Yuchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174375/
https://www.ncbi.nlm.nih.gov/pubmed/35583797
http://dx.doi.org/10.1007/s13300-022-01268-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174375/
https://www.ncbi.nlm.nih.gov/pubmed/35583797
http://dx.doi.org/10.1007/s13300-022-01268-2

Ejemplares similares